Dynavax Technologies Corporation (DVAX) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dynavax Technologies Corporation  (NASDAQ: DVAX)


Dynavax Technologies's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Dynavax Technologies's ROI in the third quarter of 2025?
Dynavax Technologies Corporation recorded a cumulative net loss of $-43 million during 12 months ending in the third quarter of 2025, resulting in a negative return on investment (ROI) of -5.07%.

Within the Healthcare sector 235 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 2362 to 2689.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM -10.14 % -4.3 % 1.51 % 4.44 % 9.16 %
Y / Y Net Income Change TTM - - - 88.18 % 43.27 %
Investment (TTM) in Millions 840 800 878 908 992
Return On Investment (TTM) -5.07 % -5.9 % -6.44 % 2.89 % 2.15 %
DVAX's Overall Ranking # 2689 # 2362 # 2228 # 851 # 1580
Seq. Investment Change TTM -4.26 % -4.12 % -1.4 % -0.72 % 1.96 %
Seq. Net Income Change TTM - - - 33.36 % 19.22 %
Net Income (TTM) in Millions -43 -53 -60 27 20

DVAX Company Profile >> Back to DVAX Roi Comparisons >> See Annual DVAX Return On Investment



Return On Investment DVAX's Ranking
Within: No.
Industry # 83
Sector # 236
Overall # 2689

Return On Investment Statistics
High Average Low
52.16 %
-35.14 %
-103.24 %
(Sep 30 2022)   (June 30. 2015)







Financial Statements
Dynavax Technologies's III. Quarter Investments $ 840 Millions DVAX's Balance sheet
Dynavax Technologies's III. Quarter Income $ 27 Millions Quarterly DVAX's Income Statement
DVAX's Income by Division See DVAX's Income by Division


DVAX Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 908 935 803 449 241
Y / Y Investment Growth -2.92 % 16.43 % 79.02 % 86.06 % 28.11 %
Net Income in Millions 27 -6 293 72 -75
Y / Y Net Income Growth - - 305.96 % - -
Annual Return On Investment 3.01 % -0.68 % 36.47 % 16.08 % -31.21 %


Annual Roi Comment
In the fiscal year 2024 ROI improved to 3.01 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DVAX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DVAX's Competitors
Subscribers only: Roi for Dynavax Technologies's Suppliers
Subscribers only: Return On Investment for DVAX's Customers

Other Ratios
DVAX's Roa DVAX's Inventory Turnover Ratio DVAX's Growth Rates DVAX's Dividend Statistics
DVAX's Profitability Ratios DVAX's Asset Turnover Ratio DVAX's Dividend Growth
DVAX's Roe DVAX's Valuation Ratios DVAX's Financial Strength Ratios DVAX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-26T07:02:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.